8Wahlgreth N,Ahmed N,Davalos A,et al. Symptmtomatic in- tracerebral hemorrhgge, mortality and independence at 3 months for patients treated 3-4. 5h after stroke onset in the sits thrombolysis register (SITS-ISTR)[J].Cerebmvasc Dis, 2008,25(Suppl 2) :3.
9Weimar LR, Kraywinkel K, Maschke M, et al. Intravenous thrombolysis in geman stroke units before and after regula- tory approval of recombinant tisue plasminogen activator U [J].CerebmvascDis, 2006,22 (5/6) : 429-431.
10Xia CF, Yin H, Yao YY. Kallikrein protects against i sehemic stroke by inhibiting apoptosis and promoting anogenesis and neurogenesis[J]. Human Gene Therapy, 2006,17 : 206-219.
